Skip to main content

Tax-Exempt Organizations

Nonprofits, philanthropists, and companies face increasing calls for greater accountability and effectiveness from direct and indirect stakeholders. Tax-exempt organizations are encountering new and complex challenges, which require creative solutions to ensure their work can be pursued with dedication, integrity, and innovation.

The Tax-Exempt Organizations team employs our comprehensive knowledge of market practices to develop innovative structures and vehicles that help clients maximize their charitable, policy, and social impact. Clients turn to us on issues involving collaborations and consortiums, complex multiparty transactions, corporate and venture philanthropy, governance, impact investing, intellectual property licensing, internal investigations, international affiliations, major gifts, and regulatory compliance, among many others. Leveraging our firm’s full breadth of experience, we provide sector-based insights and advice tailored to each client’s unique needs.

Our clients span the philanthropic sector. We advise public charities, medical research organizations, advocacy and political organizations, corporate and venture philanthropists, donor-advised funds and donor collaboratives, family offices, international organizations, academic institutions, private foundations, and prominent donors. 

"Their commercial awareness is among the best I have seen. They consistently provide updates and examples that impact the work we are doing together." — Chambers 2024
Over the last 12 months alone, the team has facilitated over US$1 billion in grants and major gifts for clients.
Read: What Trump Actions Mean For Federal Research Funding
Read: Trump Cuts to Scientific Research Funds Jeopardize Public Health

Experience Highlights

  • The Parker Institute for Cancer Immunotherapy (PICI) in structuring, negotiating and documenting an approximately US$300 million research consortium in affiliation with six U.S. academic and medical research institutions. The PICI model establishes a collaborative approach to centralize tech transfer and commercialization, and is designed to remove barriers, encourage collaboration and turn ideas into real-world cancer treatments.

  • Medical Research Organization in its US$600 million founding of a research hub in San Francisco in affiliation with one private and two public universities, and its US$250 million founding of a research hub in the mid-west with two private and one public university. The San Francisco research institution focuses on quantitative cell science, infectious disease, and technology platforms; the Chicago institution will create technologies to measure human biology and study inflammation to understand disease and discover new therapies.

  • Palo Alto Research Institute in its establishment of a US$650 million medical research organization aimed at advancing scientific research in complex diseases, including neurodegeneration, cancer and immune dysfunction. The Institute fully funds investigators who may have faculty appointments at affiliated universities; establishes technology centers that focus on machine learning, genome engineering and cellular and animal models of disease; and has a translational infrastructure that accelerates the advancement of new biotechnologies to maximize patient impact.

  • The Lieber Institute for Brain Development in its formation and affiliation with Johns Hopkins University; developed intellectual property, publications, and conflicts policies for the institute; advised on licenses and collaborations with other researchers and private companies; counseled on material transfer arrangements to establish the world’s largest repository of post-mortem human brains for the study of neuropsychiatric disorders.

  • Multiple Family Offices in structuring, managing and operating the family’s philanthropic and policy vehicles and initiatives, including individual charitable giving, supported tax-exempt organizations (including private foundations and 501(c)(4) advocacy organizations), and for-profit mission-related entities and investments.

  • In-Q-Tel, a nonprofit funded by the Central Intelligence Agency, on equity and other investments in technology companies as a way to develop and acquire cutting-edge technologies for the intelligence community, to the board and board committees on governance, compensation, conflicts, and fiduciary responsibilities, and on a wide range of regulatory matters.

  • The Markle Foundation on its general operating and philanthropic matters, including its Rework America Alliance’s efforts to expand access to quality jobs for all Americans.

  • The Joyce Foundation, a private, nonpartisan philanthropic organization, in its programmatic work to invest in public policies and strategies to advance racial equity and economic mobility.

  • ​​​​​​Women Moving Millions in strategic plans and implementation of donor collaboratives.

  • An art museum in restructuring its art collections and endowment funds using a supporting organization.

  • ​​​​​​Delterra, an environmental nonprofit working to transform entire ecosystems in waste management and recycling, in spinning out from a parent entity, establishing an international structure of affiliates to implement its work and collaboration agreements with nonprofit and for-profit partners.